Pathogen reduction of whole blood: utility and feasibility-Reference-Cited by-同舟云学术

Pathogen reduction of whole blood: utility and feasibility

Published:2017-09-05 Issue:5 Volume:27 Page:320-326
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Med

Author:

Allain J.-P.¹^ORCID,Goodrich R.²

Affiliation:

1. University of Cambridge; Cambridge UK

2. Infectious Disease Research Center; University of Colorado; Denver Colorado USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tme.12456/fullpdf

Reference38 articles.

1. Bacterial contamination of blood and blood components in three major blood transfusion centers, Accra, Ghana;Adjei;Japanese Journal of Infectious Diseases,2009

2. External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection;Ala;PLoS Medicine,2012

3. Moving on from voluntary non-remunerated donors: who is the best blood donor?;Allain;British Journal of Haematology,2011

4. Characterization of posttransfusion plasmodium falciparum infection in semi-immune nonparasitemic patients;Allain;Transfusion,2016a

5. Effect of plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African investigation of the Mirasol system (AIMS) randomised controlled trial;Allain;Lancet,2016b

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence and Determinants of Transfusion Transmissible Infections among Blood Donors in a Municipality in Ghana; A Three-year Retrospective Study;2024-09-06

2. Ultraviolet light and riboflavin accelerates red blood cell dysfunction in vitro and in a guinea pig transfusion model;BLOOD TRANSFUS-ITALY;2024

3. Transfusion safety: Is there a difference between reported reactions in low-to-middle income and high-income countries?;Transfusion and Apheresis Science;2024-06

4. The Preclinical Validation of 405 nm Light Parasiticidal Efficacy on Leishmania donovani in Ex Vivo Platelets in a Rag2−/− Mouse Model;Microorganisms;2024-01-29

5. ‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review;Infectious Disorders - Drug Targets;2022-12